1 completed, 1 terminated. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 1, Terminated 1 |
Follow AZD1208: new trials by email Literature Review of AZD1208 trials Research Report on AZD1208
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Global Phase1 Study to Assess the Safety and Tolerability of AZD1208 in Advanced Solid Tumors and Malignant Lymphoma AZD1208 - Advanced Solid Malignancies, Malignant Lymphoma | Phase 1 | Completed | AstraZeneca | 43 | 2012-07-01 | 2015-11-04 |
| Safety, Tolerability, Pharmacokinetics and Efficacy of AZD1208 in Acute Myelogenous Leukemia (AML) Patients AZD1208 - Acute Myeloid Leukemia | Phase 1 | Terminated | AstraZeneca | 55 | 2012-02-01 | 2015-08-11 |
Leukemia (1) · Leukemia, Myeloid, Acute (1) · Lymphoma (1)
AstraZeneca (2)
Canada (1) · Japan (1) · United Kingdom (1) · United States (1)
Frank Neumann, MD (1) · Frank Neumann, MSD (1)